Cargando…
Changes in vasoactive pathways in congenital diaphragmatic hernia associated pulmonary hypertension explain unresponsiveness to pharmacotherapy
BACKGROUND: Patients with congenital diaphragmatic hernia (CDH) have structural and functional different pulmonary vessels, leading to pulmonary hypertension. They often fail to respond to standard vasodilator therapy targeting the major vasoactive pathways, causing a high morbidity and mortality. W...
Autores principales: | Mous, Daphne S., Buscop-van Kempen, Marjon J., Wijnen, Rene M. H., Tibboel, Dick, Rottier, Robbert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688796/ https://www.ncbi.nlm.nih.gov/pubmed/29115963 http://dx.doi.org/10.1186/s12931-017-0670-2 |
Ejemplares similares
-
Opposing Effects of TGFβ and BMP in the Pulmonary Vasculature in Congenital Diaphragmatic Hernia
por: Mous, Daphne S., et al.
Publicado: (2021) -
Pulmonary vascular development in congenital diaphragmatic hernia
por: Mous, Daphne S., et al.
Publicado: (2018) -
Cellular Origin(s) of Congenital Diaphragmatic Hernia
por: Edel, Gabriëla G., et al.
Publicado: (2021) -
Hypoxia inducible factor 2α (HIF2α/EPAS1) is associated with
development of pulmonary hypertension in severe congenital diaphragmatic hernia
patients
por: Huang, Yadi, et al.
Publicado: (2018) -
Identification of SOX2 Interacting Proteins in the Developing Mouse Lung With Potential Implications for Congenital Diaphragmatic Hernia
por: Schilders, Kim A. A., et al.
Publicado: (2022)